Showing results (1411-1420 of 2,945) with videos related to

Sort By:
Pageof 295
Acta Diabetologica|May 6, 2026
Orthostatic hypotension as a marker of increased arterial stiffness in diabetes mellitusMerve Oruc, Ozant Helvacı, Ahmet Oruc, et al.
Acta Diabetologica|May 6, 2026
Impact of controlled type 2 diabetes on muscle-tendon mechanicsRiccardo Magris, Andrea Monte, Nicolò Vigolo, et al.
Acta Diabetologica|April 15, 2026
Role of automated insulin delivery (AID) systems in glucose control in patients with diabetes mellitus undergoing dialysis in Calabria: AID-DIAL-CALElena Succurro, Giuseppe Cersosimo, Paola Sarnelli, et al.
Acta Diabetologica|August 12, 2026
Effects of bedtime melatonin treatment on blood pressure and arterial stiffness: a three-month, randomized, placebo-controlled crossover study in individuals with type 2 diabetes mellitusEsben Stistrup Lauritzen, Julie Støy, Niels Møller, et al.
Acta Diabetologica|July 28, 2026
The association between adapted dietary index for gut microbiota and carotid intima-media thickness among overweight or obese children and adolescentsMobina Imannezhad, Ali Nikparast, Elahe Etesami, et al.
Acta Diabetologica|August 28, 2026
Predictors of first-ever major adverse cardiovascular events in newly diagnosed type 2 diabetes: a 5-year prospective cohort studyCarmine Gazzaruso, Pietro Gallotti, Colomba Falcone, et al.
Acta Diabetologica|August 27, 2026
Effects of diabetes complications on body composition, dietary intake, and metabolic parametersTuba Tekin, Başak İkra Yıldız, Şaziye Yoldaş, et al.
Acta Diabetologica|August 21, 2026
Increasing incidence and clinical burden of paediatric type 1 diabetes in Italy: insights from a large administrative databaseEnza Mozzillo, Clara Trimarchi, Raffaella Buzzetti, et al.
Acta Diabetologica|September 21, 2026
Modulation of circulating osteocalcin-expressing monocytes by glucagon like peptide-1 receptor agonists in type 2 diabetes: an exploratory pilot studyAndrea Carafa, Rosario Luigi Sessa, Rocco Amendolara, et al.
Acta Diabetologica|September 10, 2026
MASLD in type 2 diabetes: steatosis-fibrosis burden and metabolic determinants in a real-world cohortSalvatore Corrao, Salvatore Scibetta, Brenda Bongiorno, et al.
Pageof 295